IPQ Inside the global regulatory dialogue

Regulatory Transparency vs. Industry Flexibility at Issue for Starting Materials in ICH Q11

Jul 9th, 2010

Please Log in to print the full article

The ICH Q11 Expert Working Group (EWG) has been wrestling with balancing regulatory transparency with industry flexibility in defining the starting material as it moves forward in drafting the guideline on drug substance development and...

You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.

©2021 IPQ Publications